Phenytoin Sodium Injection
Product Images NDC 51662-1250

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Phenytoin Sodium (NDC 51662-1250). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Boxed Warning (Boxed Warning)

A boxed warning panel for Phenytoin Sodium Injection 50 mg/mL addressing cardiovascular risk with rapid infusion. It states the recommended maximum intravenous administration rates in adults and pediatric patients, and emphasizes the need for careful cardiac monitoring during and after infusion due to risks such as severe hypotension and cardiac arrhythmias. It also notes the possibility of toxicity at or below recommended rates and advises consideration of reducing or stopping the dose if needed.*

FDA Label Image

Interactions 2 (Drug Int 2)

A data table titled "Interacting Agent Examples" listing various drug classes and specific drugs that interact with phenytoin. It categorizes drugs whose efficacy is impaired by phenytoin, such as azoles, antineoplastic agents, neuromuscular blocking agents, warfarin, and others. It also lists drugs whose levels are decreased by phenytoin, including antiepileptic drugs, antilipidemic agents, antiviral agents, calcium channel blockers, and other medications. Additional notes on interactions and management are included in the table.*

FDA Label Image

Interactions 1 (Drug Inter 1)

A data table listing drug interactions with phenytoin sodium, categorizing drugs that may increase, decrease, or either increase or decrease phenytoin serum levels. The table includes specific examples of interacting agents, grouped by drug class such as antiepileptic drugs, azoles, antineoplastic agents, antidepressants, gastric acid reducing agents, sulfonamides, antiviral agents, and others.*

FDA Label Image

Highlights Boxed (Highlights Boxed)

A warning panel for Phenytoin Sodium Injection addressing cardiovascular risks associated with rapid infusion. It specifies that intravenous administration should not exceed 50 mg per minute in adults and 1 to 3 mg/kg/min or 50 mg per minute in pediatric patients, highlights risks of hypotension and cardiac arrhythmias, and advises careful cardiac monitoring during and after infusion.*

FDA Label Image

Serialized (Serialized 51662 1250 1 Phyentoin 5ml Vial)

Phenytoin Sodium Injection 50 mg/mL in a 5 mL single-dose vial. The label shows the strength as 250 mg per 5 mL, labeled for intravenous or intramuscular use. Distributed by HF Acquisition Co LLC, DBA HealthFirst. The vial has a brown cap and a white label with orange and blue text.*

FDA Label Image

Structure (Structure)

Chemical structure of phenytoin sodium, showing its molecular framework including aromatic rings and functional groups with sodium ion (Na) indicated.*

FDA Label Image

Vial (Vial Label)

Label for Phenytoin Sodium Injection, USP, 50 mg/mL (250 mg/5 mL) in a 5 mL single-dose vial. The label indicates the product is for intravenous or intramuscular use and includes storage instructions and barcodes. The manufacturer is indicated as HF Acquisition Co LLC, DBA HealthFirst.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.